| Shailen Jalali, MD | |
|
700 E Township Line Rd, First Floor, Havertown, PA 19083-5733 | |
| (484) 458-1000 | |
| (484) 458-1001 |
| Full Name | Shailen Jalali |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 39 Years |
| Location | 700 E Township Line Rd, Havertown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427021351 | NPI | - | NPPES |
| 1454762 | Other | NJ | AETNA |
| 54-2177172 | Other | NJ | HEALTH NET (TRICARE) |
| 54-2177172 | Other | NJ | HORIZON BLUE CROSS BLUE SHIELD |
| 051051700 | Other | PA | KEYSTONE MEDICARE 65 |
| 0012471380004 | Medicaid | PA | |
| 54-2177172 | Other | NJ | CHN |
| 1383718 | Other | NJ | CIGNA |
| 221914 | Other | NJ | US FAMILY HEALTH PLAN |
| 54-2177172 | Other | NJ | PHCS (MULTIPLAN) |
| P3729064 | Other | NJ | OXFORD |
| 0124713801 | Other | PA | AMERICHOICE |
| 2814318000 | Other | NJ | AMERIHEALTH, KHPE, PERSONAL CHOICE |
| 50279209 | Medicaid | NJ | |
| 54-2177172 | Other | NJ | PROCURA |
| 54-2177172 | Other | NJ | HORIZON CASUALITY |
| 54-2177172 | Other | NJ | FOCUS |
| 1241827 | Other | NJ | UNITED HEALTHCARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crozer Chester Medical Center | Upland, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Spine And Pain Llc | 0648358234 | 37 |
| Advanced Spine And Pain Llc | 0648358234 | 37 |
News Archive
It is said that each of us marches to the beat of a different drum, but new Stanford University research suggests that brain cells need to follow specific rhythms that must be kept for proper brain functioning.
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Memory loss after anesthesia is a common adverse event upon awakening from surgery. Unfortunately the cause of such memory loss is unknown and there are no known treatments or prevention strategies. A study published in the November 2010 issue of Anesthesiology indicates that this memory loss could be prevented by blocking a receptor thought to contribute to memory deficits. Such a treatment may be able to solve the feeling of mental confusion that surgical patients so often feel shortly after coming out of anesthesia.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Barclays Global Healthcare Conference to be held at the Loews Miami Hotel in Miami Beach, FL, March 10-13, 2014.
› Verified 3 days ago
| Entity Name | South Jersey Spine & Pain Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912075201 PECOS PAC ID: 8224131875 Enrollment ID: O20070320000209 |
News Archive
It is said that each of us marches to the beat of a different drum, but new Stanford University research suggests that brain cells need to follow specific rhythms that must be kept for proper brain functioning.
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Memory loss after anesthesia is a common adverse event upon awakening from surgery. Unfortunately the cause of such memory loss is unknown and there are no known treatments or prevention strategies. A study published in the November 2010 issue of Anesthesiology indicates that this memory loss could be prevented by blocking a receptor thought to contribute to memory deficits. Such a treatment may be able to solve the feeling of mental confusion that surgical patients so often feel shortly after coming out of anesthesia.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Barclays Global Healthcare Conference to be held at the Loews Miami Hotel in Miami Beach, FL, March 10-13, 2014.
› Verified 3 days ago
| Entity Name | Advanced Spine And Pain Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730359084 PECOS PAC ID: 0648358234 Enrollment ID: O20080423000019 |
News Archive
It is said that each of us marches to the beat of a different drum, but new Stanford University research suggests that brain cells need to follow specific rhythms that must be kept for proper brain functioning.
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Memory loss after anesthesia is a common adverse event upon awakening from surgery. Unfortunately the cause of such memory loss is unknown and there are no known treatments or prevention strategies. A study published in the November 2010 issue of Anesthesiology indicates that this memory loss could be prevented by blocking a receptor thought to contribute to memory deficits. Such a treatment may be able to solve the feeling of mental confusion that surgical patients so often feel shortly after coming out of anesthesia.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Barclays Global Healthcare Conference to be held at the Loews Miami Hotel in Miami Beach, FL, March 10-13, 2014.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shailen Jalali, MD Po Box 33465, Belfast, ME 04915-0612 Ph: (888) 985-2727 | Shailen Jalali, MD 700 E Township Line Rd, First Floor, Havertown, PA 19083-5733 Ph: (484) 458-1000 |
News Archive
It is said that each of us marches to the beat of a different drum, but new Stanford University research suggests that brain cells need to follow specific rhythms that must be kept for proper brain functioning.
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Memory loss after anesthesia is a common adverse event upon awakening from surgery. Unfortunately the cause of such memory loss is unknown and there are no known treatments or prevention strategies. A study published in the November 2010 issue of Anesthesiology indicates that this memory loss could be prevented by blocking a receptor thought to contribute to memory deficits. Such a treatment may be able to solve the feeling of mental confusion that surgical patients so often feel shortly after coming out of anesthesia.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the Barclays Global Healthcare Conference to be held at the Loews Miami Hotel in Miami Beach, FL, March 10-13, 2014.
› Verified 3 days ago